Clinical trial
A Safety and Feasibility Study of Low-intensity Anticoagulation With HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)
NCT03078374 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Feasibility Study of Low-intensity Anticoagulation With HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)
- Lead sponsor
- Institute for Clinical and Experimental Medicine
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 11, 2017
- Completion date
- October 31, 2022
- Enrollment
- 15 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.